Latest Insider Transactions at Maravai Lifesciences Holdings, Inc. (MRVI)
This section provides a real-time view of insider transactions for Maravai Lifesciences Holdings, Inc. (MRVI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARAVAI LIFESCIENCES HOLDINGS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARAVAI LIFESCIENCES HOLDINGS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 30
2021
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
916
+50.0%
|
$20,152
$22.95 P/Share
|
|
Apr 30
2021
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
495
+5.83%
|
$10,890
$22.95 P/Share
|
|
Apr 30
2021
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
286
+50.0%
|
$6,292
$22.95 P/Share
|
|
Apr 30
2021
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
497
+50.0%
|
$10,934
$22.95 P/Share
|
|
Apr 08
2021
|
Gtcr Investment Xi LLC |
SELL
Other acquisition or disposition
|
Indirect |
2,304,256
-1.58%
|
-
|
|
Apr 08
2021
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
395,744
-1.58%
|
$12,268,064
$31.25 P/Share
|
|
Apr 07
2021
|
Gtcr Investment Xi LLC |
SELL
Other acquisition or disposition
|
Indirect |
15,361,703
-9.54%
|
-
|
|
Apr 07
2021
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,638,297
-9.54%
|
$81,787,207
$31.25 P/Share
|
|
Nov 25
2020
|
Carl Hull Director |
BUY
Open market or private purchase
|
Indirect |
35,000
+50.0%
|
$910,000
$26.94 P/Share
|
|
Nov 24
2020
|
Gtcr Investment Xi LLC |
SELL
Other acquisition or disposition
|
Indirect |
7,680,852
-4.55%
|
-
|
|
Nov 24
2020
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,319,148
-4.55%
|
$32,978,700
$25.52 P/Share
|
|
Nov 24
2020
|
Kurt Oreshack General Counsel |
BUY
Open market or private purchase
|
Direct |
7,500
+50.0%
|
$202,500
$27.0 P/Share
|
|
Nov 24
2020
|
Jessica Hopfield Director |
BUY
Open market or private purchase
|
Direct |
50,000
+44.7%
|
$1,350,000
$27.0 P/Share
|
|
Nov 24
2020
|
Gregory T Lucier Director |
BUY
Open market or private purchase
|
Direct |
15,000
+35.84%
|
$405,000
$27.0 P/Share
|
|
Nov 24
2020
|
Murali Prahalad Director |
BUY
Open market or private purchase
|
Direct |
18,000
+37.62%
|
$486,000
$27.0 P/Share
|
|
Nov 24
2020
|
Robert B Hance Director |
BUY
Open market or private purchase
|
Direct |
10,000
+31.4%
|
$270,000
$27.0 P/Share
|
|
Nov 24
2020
|
Lisa Sellers Officer |
BUY
Open market or private purchase
|
Direct |
18,888
+50.0%
|
$509,976
$27.0 P/Share
|
|
Nov 24
2020
|
Susannah Gray Director |
BUY
Open market or private purchase
|
Direct |
20,000
+38.57%
|
$540,000
$27.0 P/Share
|
|
Nov 19
2020
|
Robert B Hance Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,852
+50.0%
|
-
|
|
Nov 19
2020
|
Susannah Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,852
+50.0%
|
-
|
|
Nov 19
2020
|
Anat Ashkenazi Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,852
+50.0%
|
-
|
|
Nov 19
2020
|
Murali Prahalad Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,852
+50.0%
|
-
|
|
Nov 19
2020
|
Jessica Hopfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,852
+50.0%
|
-
|
|
Nov 19
2020
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,852
+50.0%
|
-
|